CAMBRIDGE, England and WALTHAM, Mass., June 23, 2023 /PRNewswire/ -- Abcam plc ("Abcam," "Company," "Group") (Nasdaq:ABCM), a global leader in the supply of life science research tools, today announces that, having listened to and extensively engaged with shareholders, the Board of Directors has unanimously decided to initiate a process to explore strategic alternatives for the Company. The comprehensive process will begin immediately and will evaluate a broad range of options to maximize shareholder value, including a potential sale of the Company. As previously disclosed, Abcam has received strategic inquiries from multiple parties over the past few weeks.
Read more at prnewswire.comAbcam Announces Review of Strategic Alternatives
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Semiconductor%20Chip%20by%20Gorodenkoff%20via%20Shutterstock.jpg)
/Oracle%20Corp_%20office%20logo-by%20Mesut%20Dogan%20via%20iStock.jpg)